Pharmacokinetics of Azithromycin, Levofloxacin, and Ofloxacin in Rabbit Extraocular Tissues After Ophthalmic Administration
Abstract Introduction Azithromycin demonstrates high tissue distribution and prolonged elimination half-life. In this study, we monitored the pharmacokinetics of a single ophthalmic administration of 1% azithromycin ophthalmic solution containing polycarbophil in the extraocular tissues, including t...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2019-08-01
|
Series: | Ophthalmology and Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1007/s40123-019-00205-0 |
id |
doaj-8d94c9fa313e40fca35a37115d6792ce |
---|---|
record_format |
Article |
spelling |
doaj-8d94c9fa313e40fca35a37115d6792ce2020-11-25T02:37:15ZengAdis, Springer HealthcareOphthalmology and Therapy2193-82452193-65282019-08-018451151710.1007/s40123-019-00205-0Pharmacokinetics of Azithromycin, Levofloxacin, and Ofloxacin in Rabbit Extraocular Tissues After Ophthalmic AdministrationTatsuya Sakai0Keisuke Shinno1Masaaki Kurata2Akio Kawamura3Research and Development Division, Senju Pharmaceutical Co., Ltd.Research and Development Division, Senju Pharmaceutical Co., Ltd.Research and Development Division, Senju Pharmaceutical Co., Ltd.Research and Development Division, Senju Pharmaceutical Co., Ltd.Abstract Introduction Azithromycin demonstrates high tissue distribution and prolonged elimination half-life. In this study, we monitored the pharmacokinetics of a single ophthalmic administration of 1% azithromycin ophthalmic solution containing polycarbophil in the extraocular tissues, including the eyelid, and compared it with that of two commercial ophthalmic products, 1.5% levofloxacin ophthalmic solution and 0.3% ofloxacin ophthalmic ointment. Methods Rabbits were treated with either a single topical administration of 1% azithromycin ophthalmic solution, 1.5% levofloxacin ophthalmic solution, or 0.3% ofloxacin ophthalmic ointment. The eyelid, conjunctiva, and cornea were collected at 0.25, 0.5, 1, 2, 4, 8, and 24 h post-administration. Tissue samples were pretreated for drug concentration measurements by ultra-performance liquid chromatography-tandem mass spectrometry. Pharmacokinetic parameters were determined by non-compartmental analysis. Results Azithromycin was rapidly absorbed, and its levels remained near the observed maximum concentrations for up to 24 h post-administration in all tissue. In contrast, extraocular tissue concentrations of levofloxacin and ofloxacin decreased with time. The maximum concentrations of azithromycin, levofloxacin, and ofloxacin were 35.6, 34.1, and 55.1 µg/g in the eyelid, 44.2, 46.8, and 20.4 µg/g in the conjunctiva, and 79.9, 18.0, and 2.21 µg/g in the cornea, respectively. The values of the area under the curve from 0 to 24 h after administration of azithromycin, levofloxacin, and ofloxacin were 602, 58.5, and 267 µg·h/g in the eyelid, 837, 43.2, and 51.9 µg·h/g in the conjunctiva, and 1250, 26.4, and 5.46 µg h/g in the cornea, respectively. Conclusion The drug concentrations of azithromycin and levofloxacin were relatively comparable among the extraocular tissues following topical administration of the respective ophthalmic solutions, whereas the concentrations of ofloxacin varied following dosing of its ophthalmic ointment. The slow elimination profile in any extraocular tissue of rabbits was unique to azithromycin, and led to the demonstration of high exposures of azithromycin in all extraocular tissues after ophthalmic administration. Funding This research and Rapid Service Fees were supported by Senju Pharmaceutical Co., Ltd.http://link.springer.com/article/10.1007/s40123-019-00205-0AzithromycinConjunctivaCorneaDrug concentration profileEyelidLevofloxacin |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Tatsuya Sakai Keisuke Shinno Masaaki Kurata Akio Kawamura |
spellingShingle |
Tatsuya Sakai Keisuke Shinno Masaaki Kurata Akio Kawamura Pharmacokinetics of Azithromycin, Levofloxacin, and Ofloxacin in Rabbit Extraocular Tissues After Ophthalmic Administration Ophthalmology and Therapy Azithromycin Conjunctiva Cornea Drug concentration profile Eyelid Levofloxacin |
author_facet |
Tatsuya Sakai Keisuke Shinno Masaaki Kurata Akio Kawamura |
author_sort |
Tatsuya Sakai |
title |
Pharmacokinetics of Azithromycin, Levofloxacin, and Ofloxacin in Rabbit Extraocular Tissues After Ophthalmic Administration |
title_short |
Pharmacokinetics of Azithromycin, Levofloxacin, and Ofloxacin in Rabbit Extraocular Tissues After Ophthalmic Administration |
title_full |
Pharmacokinetics of Azithromycin, Levofloxacin, and Ofloxacin in Rabbit Extraocular Tissues After Ophthalmic Administration |
title_fullStr |
Pharmacokinetics of Azithromycin, Levofloxacin, and Ofloxacin in Rabbit Extraocular Tissues After Ophthalmic Administration |
title_full_unstemmed |
Pharmacokinetics of Azithromycin, Levofloxacin, and Ofloxacin in Rabbit Extraocular Tissues After Ophthalmic Administration |
title_sort |
pharmacokinetics of azithromycin, levofloxacin, and ofloxacin in rabbit extraocular tissues after ophthalmic administration |
publisher |
Adis, Springer Healthcare |
series |
Ophthalmology and Therapy |
issn |
2193-8245 2193-6528 |
publishDate |
2019-08-01 |
description |
Abstract Introduction Azithromycin demonstrates high tissue distribution and prolonged elimination half-life. In this study, we monitored the pharmacokinetics of a single ophthalmic administration of 1% azithromycin ophthalmic solution containing polycarbophil in the extraocular tissues, including the eyelid, and compared it with that of two commercial ophthalmic products, 1.5% levofloxacin ophthalmic solution and 0.3% ofloxacin ophthalmic ointment. Methods Rabbits were treated with either a single topical administration of 1% azithromycin ophthalmic solution, 1.5% levofloxacin ophthalmic solution, or 0.3% ofloxacin ophthalmic ointment. The eyelid, conjunctiva, and cornea were collected at 0.25, 0.5, 1, 2, 4, 8, and 24 h post-administration. Tissue samples were pretreated for drug concentration measurements by ultra-performance liquid chromatography-tandem mass spectrometry. Pharmacokinetic parameters were determined by non-compartmental analysis. Results Azithromycin was rapidly absorbed, and its levels remained near the observed maximum concentrations for up to 24 h post-administration in all tissue. In contrast, extraocular tissue concentrations of levofloxacin and ofloxacin decreased with time. The maximum concentrations of azithromycin, levofloxacin, and ofloxacin were 35.6, 34.1, and 55.1 µg/g in the eyelid, 44.2, 46.8, and 20.4 µg/g in the conjunctiva, and 79.9, 18.0, and 2.21 µg/g in the cornea, respectively. The values of the area under the curve from 0 to 24 h after administration of azithromycin, levofloxacin, and ofloxacin were 602, 58.5, and 267 µg·h/g in the eyelid, 837, 43.2, and 51.9 µg·h/g in the conjunctiva, and 1250, 26.4, and 5.46 µg h/g in the cornea, respectively. Conclusion The drug concentrations of azithromycin and levofloxacin were relatively comparable among the extraocular tissues following topical administration of the respective ophthalmic solutions, whereas the concentrations of ofloxacin varied following dosing of its ophthalmic ointment. The slow elimination profile in any extraocular tissue of rabbits was unique to azithromycin, and led to the demonstration of high exposures of azithromycin in all extraocular tissues after ophthalmic administration. Funding This research and Rapid Service Fees were supported by Senju Pharmaceutical Co., Ltd. |
topic |
Azithromycin Conjunctiva Cornea Drug concentration profile Eyelid Levofloxacin |
url |
http://link.springer.com/article/10.1007/s40123-019-00205-0 |
work_keys_str_mv |
AT tatsuyasakai pharmacokineticsofazithromycinlevofloxacinandofloxacininrabbitextraoculartissuesafterophthalmicadministration AT keisukeshinno pharmacokineticsofazithromycinlevofloxacinandofloxacininrabbitextraoculartissuesafterophthalmicadministration AT masaakikurata pharmacokineticsofazithromycinlevofloxacinandofloxacininrabbitextraoculartissuesafterophthalmicadministration AT akiokawamura pharmacokineticsofazithromycinlevofloxacinandofloxacininrabbitextraoculartissuesafterophthalmicadministration |
_version_ |
1724795828815527936 |